Genscript Biotech (GNNSF) Cash flow

22 Followers

Genscript Biotech Cash Flow

GNNSF's free cash flow for Q2 2026 was $9.10M. For the 2026 fiscal year, GNNSF's free cash flow was decreased by $313.96M and operating cash flow was $56.68M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 325.52M	$ 75.65M	$ -286.91M	$ -120.29M	$ -136.79M
Investing Cash Flow	$ -171.95M	$ -1.46B	$ -357.73M	$ -443.30M	$ -212.55M
Financing Cash Flow	$ -144.89M	$ 66.52M	$ 1.07B	$ 419.32M	$ 902.14M
End Cash Position	$ 142.49M	$ 131.99M	$ 1.45B	$ 1.02B	$ 1.18B
Free Cash Flow	$ 241.69M	$ -72.27M	$ -444.62M	$ -336.40M	$ -269.83M

Currency in USD